Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Avient
AVNT
$4.23B
| $6.32M | ﹤0.01% |
202,227
-17,010
| -8% | -$526K |
|
2027
Expro Ltd
XPRO
$2.1B
| $6.3M | ﹤0.01% |
472,047
-21,362
| -4% | -$288K |
|
|
RAL
2028
Ralliant Corp
RAL
$7.9B
| $6.29M | ﹤0.01% |
123,464
+35,212
| +40% | +$1.65M |
|
2029
Viavi Solutions
VIAV
$10.6B
| $6.26M | ﹤0.01% |
351,419
+23,395
| +7% | +$378K |
|
2030
Patrick Industries
PATK
$2.78B
| $6.26M | ﹤0.01% |
57,753
+4,658
| +9% | +$489K |
|
2031
Phinia Inc
PHIN
$2.7B
| $6.26M | ﹤0.01% |
99,847
+43,926
| +79% | +$2.43M |
|
2032
Outfront Media
OUT
$5.24B
| $6.26M | ﹤0.01% |
259,647
-127,461
| -33% | -$2.65M |
|
2033
Rush Enterprises Class A
RUSHA
$9.62B
| $6.24M | ﹤0.01% |
115,692
+14,275
| +14% | +$742K |
|
2034
Ligand Pharmaceuticals
LGND
$5.76B
| $6.24M | ﹤0.01% |
32,982
+2,699
| +9% | +$519K |
|
2035
Griffon
GFF
$4.8B
| $6.24M | ﹤0.01% |
84,668
+15,637
| +23% | +$1.16M |
|
2036
Peabody Energy
BTU
$2.94B
| $6.24M | ﹤0.01% |
209,953
+17,297
| +9% | +$508K |
|
2037
Mueller Water Products
MWA
$3.98B
| $6.23M | ﹤0.01% |
261,545
+37,008
| +16% | +$917K |
|
2038
GitLab
GTLB
$7.32B
| $6.21M | ﹤0.01% |
165,584
+25,466
| +18% | +$1.1M |
|
2039
Twist Bioscience
TWST
$7.86B
| $6.16M | ﹤0.01% |
194,071
-32,597
| -14% | -$1.02M |
|
2040
Vornado Realty Trust
VNO
$7.41B
| $6.15M | ﹤0.01% |
184,763
-124,312
| -40% | -$4.54M |
|
2041
CALL
Rigetti Computing
RGTI
$6.21B
| $6.15M | ﹤0.01% |
277,500
+276,600
| +30,733% | +$9.02M |
|
2042
Renasant Corp
RNST
$4B
| $6.14M | ﹤0.01% |
174,353
+34,776
| +25% | +$1.23M |
|
|
PR
2043
Permian Resources
PR
$17.7B
| $6.13M | ﹤0.01% |
436,621
-786,246
| -64% | -$10.6M |
|
2044
CALL
Darling Ingredients
DAR
$10.4B
| $6.12M | ﹤0.01% |
170,000
-34,500
| -17% | -$1.17M |
|
2045
Qorvo
QRVO
$8.68B
| $6.11M | ﹤0.01% |
72,329
-8,181
| -10% | -$722K |
|
2046
Axcelis
ACLS
$4.42B
| $6.1M | ﹤0.01% |
75,982
+6,397
| +9% | +$536K |
|
|
STUB
2047
CALL
StubHub Holdings
STUB
$2.88B
| $6.09M | ﹤0.01% |
+450,000
| New | +$7.07M |
|
2048
Cushman & Wakefield Ltd
CWK
$3.37B
| $6.08M | ﹤0.01% |
375,253
+36,927
| +11% | +$585K |
|
2049
LKQ Corp
LKQ
$6.38B
| $6.07M | ﹤0.01% |
201,088
-634,749
| -76% | -$19.1M |
|
2050
Hilton Grand Vacations
HGV
$3.49B
| $6.07M | ﹤0.01% |
135,577
-2,541
| -2% | -$108K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.